Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Los investigadores evaluaron los dos tratamientos para el TDAH más comunes en Estados Unidos y encontraron que, aunque el riesgo de psicosis es bajo, es mayor para los pacientes que toman anfetaminas que para los que toman metilfenidatos.
Among adolescents and young adults with ADHD who were receiving prescription stimulants, new-onset psychosis occurred in approximately 1 in 660 patients. Amphetamine use was associated with a greater risk of psychosis than methylphenidate. We assessed 337,919 adolescents and young adults who received a prescription for a stimulant for ADHD.
“Las personas que han tomado anfetaminas durante mucho tiempo y las toleran bien, no es probable que experimenten el problema”
https://www.nejm.org/doi/10.1056/NEJMoa1813751
